Crossmark

Melatonin ameliorates disease severity in a mouse model of multiple sclerosis by modulating the kynurenine pathway

Published Online: 2022-09-24

Authors

Jand, Yahya

Ghahremani, Mohammad Hossein

Ghanbari, Amir

Ejtemaei-Mehr, Shahram

Guillemin, Gilles J.

Ghazi-Khansari, Mahmoud
License Information

Text and Data Mining valid from 2022-09-24

Version of Record valid from 2022-09-24
More Information

Article History

Received: 19 March 2022

Accepted: 9 September 2022

First Online: 24 September 2022

Competing interests

: The authors declare no competing interests.

Document is current